Biochemistry of Alzheimer's disease
Professor Donna Wilcock explains that neurotransmitter hypotheses of Alzheimer's disease are largely unspecific. Nevertheless, glutamate, serotonin, and NPY have elicited interest.
Neurotransmitters â€“ many have been implicated in disease, and it really depends on what paper you read. You could pick a neurotransmitter, and out there somewhere is a paper that shows that that neurotransmitter is affected. Glutamate, we know, is the major neurotransmitter involved in long-term potentiation (LTP), and itâ€™s thought that LTP is the mechanism for formation of memory. So glutamate has really been a big for focus for Alzheimerâ€™s [disease], for obvious reasons, that if we can maybe enhance the glutamate effect, we might enhance memory. But the problem is, if you have too much glutamate, you can actually kill the neuron, because they get overexcited, something called excitotoxicity. We have to be very careful with glutamate, and glutamate is really globally expressed through the brain; itâ€™s one of the major transmitters in the brain, so we have to be careful with that. Another one is serotonin, but serotonin is involved in a lot of behavior (e.g. depression). We know that there are some emotional issues later on in Alzheimerâ€™s disease, in the middle to late stage Alzheimerâ€™s disease. So, treatment at that stage for those patients with antidepressants that would target serotonin does seem to be beneficial for the emotional aspect of the disease, more so than memory. The other neurotransmitter is something called neuropeptide Y (NPY), and this seems to be important for blood flow. If we can increase blood flow in the brain, possibly you would be providing more oxygen and more nutrients to the brain to make it healthier. But really there is no good understanding as far as, is it one population? In Parkinsonâ€™s disease, we know that itâ€™s the dopaminergic neurons that are specifically affected. Itâ€™s a very small part of the brain, and so trying to regenerate those or put back that neurotransmitter is really a very clear goal in Parkinsonâ€™s disease, but in Alzheimerâ€™s disease, itâ€™s not that clear cut.
alzheimer, neurotransmitter, biochemical, biochemistry, glutamate, serotonin, npy, dopaminergic, donna, wilcock
An overview of Alzheimer's disease-related content on Genes to Cognition Online.
Doctor Jon Lieberman discusses three neurotransmitters that have been associated with depression - dopamine, serotonin, and norepinephrine.
Doctor Ellen Leibenluft discusses some of the biochemicals that have been associated with bipolar disorder, including dopamine, serotonin, and glutamate.
Professor Philip Shaw discusses the relationship between serotonin and ADHD.
Professor Donna Wilcock discusses early-onset Alzheimer's disease, which can reach an advanced stage by the age of 50 or 60 years.
Professor Donna Wilcock discusses Alzheimer's disease in the light of increasing prevalence as the population ages.
Doctor Josh Dubnau explains that the genes active in different neurons can make them excitatory (e.g. glutamate) or inhibitory (e.g. GABA). These neurotransmitters are critical to learning.
Professor Donna Wilcock explains that Alzheimer's disease is diagnosed clinically by a battery of tests that can take a full day to administer.
Serotonin is the biochemical most commonly associated with depression. Professor Wayne Drevets discusses other systems including norepinephrine, glutamate, and dopamine.
Professor Donna Wilcock describes amyloid plaques as clumps of protein in the brain that are one of the three hallmarks of Alzheimer's disease.